Andrew Davis

Andrew Davis

Corporate Officer/Principal chez DYNAVAX TECHNOLOGIES CORPORATION
40 ans
Health Technology
Consumer Services

Profil

Andrew Davis is currently Director at UTILITY therapeutics Ltd. since 2019 and Chief Business Officer at Dynavax Technologies Corp.
starting in 2024.
Formerly, Mr. Davis was Chairman at VectivBio Holding AG; Director at BioMarck Pharmaceuticals Ltd. from 2020 to 2022; Senior Vice President-Business Development at Ironwood Pharmaceuticals, Inc. in 2021; Senior Vice President-Business Development at Bausch Health US LLC from 2014 to 2016; Vice President-Corporate Development at Bausch Health Cos., Inc.; Chief Business Development Officer at iNova Pharmaceuticals (Pty) Ltd. (South Africa) from 2017 to 2021; and Head-Oncology Business Development at Merck & Co., Inc. from 2016 to 2017.
Education includes undergraduate studies at Boston University.

Postes actifs de Andrew Davis

SociétésPosteDébut
DYNAVAX TECHNOLOGIES CORPORATION Corporate Officer/Principal 01/11/2024
Directeur/Membre du Conseil 01/08/2019

Anciens postes connus de Andrew Davis

SociétésPosteFin
IRONWOOD PHARMACEUTICALS, INC. Corporate Officer/Principal 22/11/2024
Directeur/Membre du Conseil 01/10/2022
Corporate Officer/Principal 01/05/2021
MERCK & CO., INC. Corporate Officer/Principal 01/09/2017
Corporate Officer/Principal 01/01/2016
Voir l'expérience en détail de Andrew Davis

Formation de Andrew Davis

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

15

Relations au 1er degré

10

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées10

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Andrew Davis
🔇